Clinical Trials Browser

Not yet recruiting × OTHER × Genitourinary × Clear all

NCT07480044 2026-03-18

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Phase NA Not yet recruiting

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07322263 2026-03-17

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT07474064 2026-03-17

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Phase 2 Not yet recruiting

Muscle Invasive Bladder Cancer (MIBC)

NCT07476677 2026-03-17

ANDARP

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07478536 2026-03-17

CHAS3

Not yet recruiting

Neoplasms, Prostatic Neoplasms

NCT07465458 2026-03-16

RASROP-003

Not yet recruiting

Carcinoma, Renal Cell

NCT07468838 2026-03-16

UroDNA

Not yet recruiting

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT07475533 2026-03-16

Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07332351 2026-03-13

TRIFECTA

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT07463092 2026-03-13

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Phase NA Not yet recruiting

Prostatic Neoplasms, Sarcopenia

NCT07468903 2026-03-13

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07140315 2026-03-12

DK222 Study at Hopkins

Phase 1 Not yet recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

Phase NA Not yet recruiting

GastrointestinalGenitourinaryThoracic

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07077083 2026-03-11

CAIX PET/CT

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07441837 2026-03-11

TeLuNa

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07463833 2026-03-11

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

Phase NA Not yet recruiting

Neoplasms, Prostatic Neoplasms

NCT07463963 2026-03-11

RUPTURE

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

NCT07460206 2026-03-10

PRELUDE

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07460245 2026-03-10

AVESEC

Phase 2 Not yet recruiting

Carcinoma, Transitional Cell

NCT07460726 2026-03-10

PRIAPUS-PCa

Not yet recruiting

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT07455903 2026-03-06

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07297160 2026-03-04

CALySSEY

Phase 1 Not yet recruiting

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07437482 2026-03-03

CLEAR-PC

Not yet recruiting

Disease, Prostatic Neoplasms

NCT07444983 2026-03-03

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07224009 2026-03-02

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07441889 2026-03-02

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Phase 1/2 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06987045 2026-02-27

TransPRIDE

Not yet recruiting

Prostatic Neoplasms

NCT07123090 2026-02-27

SPARCC

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07243067 2026-02-27

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07401875 2026-02-27

A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)

Phase 1 Not yet recruiting

Kidney Neoplasms

NCT07439120 2026-02-27

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Transitional Cell

NCT07440641 2026-02-27

RE-FIT

Phase NA Not yet recruiting

Motor Activity, Prostatic Neoplasms

NCT06834204 2026-02-25

ACCESS-PC

Phase NA Not yet recruiting

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07406087 2026-02-25

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Phase NA Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07433140 2026-02-25

PROSTIMERSBOP

Phase NA Not yet recruiting

Agnosia, Prostatic Neoplasms

NCT07278362 2026-02-23

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Phase 4 Not yet recruiting

Eunuchism, Prostatic Neoplasms

NCT07426055 2026-02-23

PRO-BOOST-LC

Phase 2/3 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07426094 2026-02-23

PRO-BOOST-N

Phase 2/3 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT07420855 2026-02-19

ARON-2PLUS

Not yet recruiting

Locally Advanced or Metastatic Urothelial Cancer

NCT07332832 2026-02-18

SEQ-bpMRI

Not yet recruiting

Prostatic Neoplasms

NCT07377006 2026-02-18

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT05521698 2026-02-17

Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

Phase 1 Not yet recruiting

Non-Muscle Invasive Bladder Urothelial Carcinoma

NCT07234981 2026-02-17

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Patients With Recurrent Prostate Cancer After Prostatectomy

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07413523 2026-02-17

ASTRA

Phase NA Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07414940 2026-02-17

ACT-RESoLUTE

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07414992 2026-02-17

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT07415135 2026-02-17

Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07008833 2026-02-12

REDEMPTED

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis